Predictive risk factors of recurrence in breast cancer after neoadjuvant treatment: the NEORISK study

Franco Antonio1, Luisa Carbognin2, Ida Paris3

  • 1Breast Unit, Department of Women, Children and Public Health Sciences, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy.

Abstract